Oral doxycycline for non-systemic urinary tract infections (UTIs) due to P. aeruginosa and other Gram negative uropathogens

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 11, 2012, Pages 2865-2868

  Cunha, B A ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; CEPHALOSPORIN; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; METHENAMINE; METHENAMINE HIPPURATE; METHENAMINE MANDELATE; MINOCYCLINE; NALIDIXIC ACID; NITROFURANTOIN; OXOLINIC ACID; PENICILLIN G; PENICILLIN V; SULFONAMIDE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIUM CULTURE; BACTERIURIA; CATHETER INFECTION; CYSTITIS; DRUG COST; ENTEROBACTERIACEAE INFECTION; ENTEROCOCCAL INFECTION; ERADICATION THERAPY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; GRAM NEGATIVE INFECTION; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; KIDNEY FAILURE; KLEBSIELLA INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEUS INFECTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; PYURIA; REVIEW; TREATMENT OUTCOME; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE; URINE PH;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; DOXYCYCLINE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; URINE;

EID: 84867992480     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1680-0     Document Type: Review

References (33)

1. Stamey TA, Fair WR, Timothy MM, Millar MA, Mihara G, Lowery YC (1974) Serum versus urinary antimicrobial concentrations in cure of urinary-tract infections. N Engl J Med 291:1159-1163
2. Hulbert J (1972) Gram-negative urinary infection treated with oral penicillin G. Lancet 12:1216
3. Holloway WJ (1972) The use of oral penicillins and cephalosporins in the treatment of urinary tract infections. J Clin Pharmacol 1:1-6
4. Feit RM, Fair WR (1979) The treatment of infection stones with penicillin. J Urol 122:592-594
5. Cunha BA (2012) Antibiotic essentials, 11th edn. Jones & Bartlett, Sudbury
6. Cunha BA, Comer JB (1979) Pharmacokinetic considerations in the treatment of urinary tract infections. Conn Med 43:347-353
7. Geddes AM, Gould I (2010) Phenoxypenicillins. In: Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR (eds) Kucers' the use of antibiotics. Hodder Arnold, London, pp 59-64
8. Geddes AM, Gould IM (2010) Ampicillin, amoxicillin and other ampicillin-like penicillins. In: Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR (eds) Kucers' the use of antibiotics. Hodder Arnold, London, pp 65-92
9. Mukerji AC, Sharma MM, Taneja OP, Saxena SN, Bhatnagar RK, Ghosh-Ray B (1969) A clinical trial of alpha-6-deoxyoxytetracycline (doxycycline) in the treatment of urinary tract infections. Chemotherapy 14:77-85
10. Musher DM, Minuth JN, Thorsteinsson SB, Holmes T (1975) Effectiveness of achievable urinary concentrations of tetracyclines against tetracycline- resistant pathogenic bacteria. J Infect Dis 131:S40-S44
11. Eisen D (2010) Tetracycline. In: Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR (eds) Kucers' the use of antibiotics. Hodder Arnold, London, pp 843-851
12. Eisen DP (2010) Doxycycline. In: Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR (eds) Kucers' the use of antibiotics. Hodder Arnold, London, pp 851-869
13. Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR, (eds) (2010) Minocycline. In: Kucers' the use of antibiotics. Hodder Arnold, London, pp 870-880
14. Cunha BA (2011) Multidrug-resistant gram-negative bacilli causing urinary tract infections: clinical considerations. J Chemother 23:171-174
15. Cunha BA, Schoch P, Hage JE (2012) Oral therapy of catheter-associated bacteriuria (CAB) in the era of antibiotic resistance: nitrofurantoin revisited. J Chemother 24:122-124
16. Meier S, Weber R, Zbinden R, Ruef C, Hasse B (2011) Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 39:333-340
17. Doern GV, Brecher SM (2011) The clinical predictive value (or lack thereof) of the results of in vitro antimicrobial susceptibility tests. J Clin Microbiol S11-S14
18. Stamey TA (1972) Urinary infections. Williams & Wilkins, Baltimore, pp 31-53, 253-269
19. Comer JB, Ristuccia PA, Digamon M, Cunha BA (1984) Urine. In: Ristuccia AM, Cunha BA (eds) Antimicrobial Therapy. Raven Press, New York, pp 487-488
20. Hollick GE, Washington JA (1976) Comparison of direct and standardized disk diffusion susceptibility testing of urine cultures. Antimicrob Agents Chemother 9:804-809
21. Breteler KK, Rentenaar RJ, Verkaart G, Sturm PDJ (2011) Performance and clinical significance of direct antimicrobial susceptibility testing on urine from hospitalized patients. Scand J Infect Dis 43:771-776
22. McNulty CAM, Richards J, Livermore DM, Little P, Charlett A, Freeman E, Harvey I, Thomas M (2006) Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother 58:1000-1008
23. Cunha BA (2006) The clinical significance of resistant uropathogens in ambulatory urinary tract infections in woman. Scand J Infect Dis 38:235-236
24. Cunha BA, Klein NC, Hamid NS (2005) Falsely high antibiotic resistance in community-acquired E. coli UTIs requiring hospitalization. Mayo Clin Proc 80:824-828
25. Cunha BA (1997) Problems arising in antimicrobial therapy due to false susceptibility testing. J Chemother 1:25-35
26. Ristuccia PA, Cunha BA (1986) Activity of antimicrobial agents at urinary concentrations against ampicillin-resistant E. coli in human urine. Adv Ther 3:163-167
27. Cunha BA (2012) Predicting in vivo effectiveness from in vitro susceptibility: a step closer to performing testing of uropathogens in human urine. Scand J Infect Dis 44:(in press)
28. Burd E, Kehl S (2011) A critical appraisal of the role of the clinical microbiology laboratory in the diagnosis of urinary tract infections. J Clin Microbiol 49:S34-S38
29. Frimodt-Moller N (2010) Fosfomycin. In: Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR (eds) Kucers' the use of antibiotics. Hodder Arnold, London, pp 935-944
30. Auer S, Wonja A, Hell M (2010) Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta- lactamase-producing Escherichia coli. Antimicrob Agents Chemother 54:4006-4008
31. Grayson ML, Whitby M (2010) Methenamine mandelate and methenamine hippurate. In: Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR (eds) Kucers' the use of antibiotics. Hodder Arnold, London, pp 1205-1210
32. Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE (2010) Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta lactamase producing, Enterobacteriaceae infections: a systemacic review. Lancet Infect Dis 10:43-50
33. Michalopoulos AS, Livaditis IG, Gougoutas V (2011) The revival of fosfomycin. Int J Infect Dis 15:e732-739